Michael W. Bevers
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
About Dr. Michael W. Bevers
Dr. Michael W. Bevers, Professor in the Department of Gynecologic Oncology and Director of the Gynecologic Oncology Outreach Program since 2008, has been named the September 2006 Educator of the Month. Since arriving at M.D. Anderson in 1994, Dr. Bevers has been instrumental in both education of young physicians and treatment of gynecologic cancers at several institutions in the Houston area. Specifically, he has been an instructor for two Professional Education for Prevention and Early Detection courses, a Department of Surgical Oncology course, and a Medical Oncology Review Course on topics related to gynecologic oncology at M.D. Anderson; a course on surgical complications in the Departments of Obstetrics and Gynecology at The University of Texas Health Science Center at Houston; a course on endometrial cancer at Baylor College of Medicine; and a course on pelvic surgery and anatomy at The University of Texas Medical School at Houston. In addition, Dr. Bevers led a Novartis Preceptorship Lecture Series on treatment of ovarian cancer at M.D. Anderson in 2000 and was a Co-Chairman of the Early Detection of Women's Cancers - Partnering with the Women's Health Community meeting at M.D. Anderson in 2005. On the treatment side, Dr. Bevers has been a prime mover in providing gynecologic oncology services in Houston as Director of the Gynecologic Oncology Outreach Program. This program, which began with the establishment of outreach relationships between M.D. Anderson and six other hospitals in the community, greatly expanding the diagnostic and treatment options for patients with gynecologic cancers. Dr. Bevers was honored for his educational work with the Association of Professors of Gynecologiy and Obstetrics Excellence in Teaching Award and in 2003 with the M.D. Anderson Outstanding Educator Award and the Baylor College of Medicine Gynecologic Exceptional Teaching Award. Furthermore, he has been on the Best Doctors in America list every year since 2003, was named to the America's Top Obstetricians and Gynecologists list in 2004, and was named a Texas Super-Doc from 2004 to 2008.
Dr. Bevers received his M.D. degree from The University of Texas Health Science Center at San Antonio in 1990. After completing an internship in 1991 and residency in Obstetrics and Gynecology in 1994 at Parkland Memorial Hospital at The University of Texas Southwestern Medical School at Dallas, Dr. Bevers came to M.D. Anderson as a Fellow in Gynecologic Oncology and a Junior Faculty Associate in the Department of Gynecologic Oncology. In 1996, Dr. Bevers was promoted to Assistant Professor of Gynecologic Oncology and named Director of Gynecologic Oncology Medical Information Systems and Coordinator of the St. Luke's Gynecologic Oncology Outreach Pilot. After being named Director of the Gynecologic Oncology Outreach Program in 2001, Dr. Bevers was promoted to Associate Professor in the Department of Gynecologic Oncology in 2002. Dr. Bevers has been a member of the M.D. Anderson Fellowship Planning Committee since 2003 and the M.D. Anderson Surgery Working Group since 2005. He is also a member of the active, provisional, or consulting staff of seven local hospitals. In addition to his numerous clinical and educational duties, Dr. Bevers has served on the Government Affairs Committee of the Society of Clinical Gynecologists since 1997 and as Editor of the Handbook of Gynecologic Oncology since 1999. During his time at M.D. Anderson, Dr. Bevers has written numerous articles published in refereed journals, abstracts, and book chapters on an array of topics pertaining to gynecologic cancer.
Present Title & Affiliation
Primary Appointment
Professor (non-tenure track), Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1990 | The University of Texas Health Science Center, San Antonio, Texas, US, MD |
| 1985 | Texas Wesleyan University, Fort Worth, Texas, US, BS in Biology |
Postgraduate Training
| 1994-1996 | Clinical Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Hospital Cancer Center, Houston, Texas |
| 1991-1994 | Clinical Residency, Obstetrics and Gynecology, The University of Texas Southwestern Medical School, Dallas, Texas |
| 1990-1991 | Clinical Internship, The University of Texas Southwestern Medical School, Dallas, Texas |
Licenses & Certifications
| 2006 | DEA |
| 2001 | American Board of Obstetrics and Gynecology, Diplomate |
| 1997 | American Board of Obstetrics and Gynecology |
| 1994 | Texas Medical License |
Experience & Service
Faculty Academic Appointments
Associate Professor (non-tenure track), Department of Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 2002 - 2008
Assistant Professor (non-tenure track), Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2002
Junior Faculty Associate, Gynecologic Oncology and Reproductive Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 1994 - 1996
Instructor, Professional Youth Conservatory, Fort Worth, TX, 1985 - 1986
Administrative Appointments/Responsibilities
Coordinator, Department of Gynecologic Oncology Monthly Morbidity and Mortality Conference, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2015
Chair, Gynecologic Oncology Outreach Program Task Force, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2012
Member, Surgery Working Group, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2011
Member, Faculty Leadership Committee, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2008
Member, Fellowship Planning Committee, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2010
Director, Gynecologic Oncology Outreach Program, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2012
Coordinator, Gynecologic Oncology Outreach Pilot, St. Luke's Episcopal Hospital, Houston, TX, 1996 - 2000
Director, Gynecologic Medical Information Systems, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology, Houston, TX, 1996 - 1999
Other Professional Positions
Member, Peer Review Committee, St. Luke's Episcopal Hospital, Houston, TX, 2008 - 2012
Chief Gynecology Service, Baylor College of Medicine, St. Luke's Episcopal Hospital, Houston, TX, 2008 - 2010
Member, Department Leadership Team, Department of Gynecologic Oncology, St. Luke's Episcopal Hospital, Houston, TX, 2006 - 2012
Member, Medical Executive Committee, St. Luke's Episcopal Hospital, Houston, TX, 2004 - 2007
Member, Cancer Committee, St. Luke's Episcopal Hospital, Houston, TX, 1998 - 2012
Member, Cancer Committee, Hermann Hospital, Houston, TX, 1998 - 2010
Extramural Institutional Committee Activities
Member, ONE MDAnderson Task Force, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Medical Practice Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Division of Surgery Cancer Network Operations Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, CancerWISE Community Speakers Bureau, The University of Texas MD Anderson Cancer Center, 1996 - Present
Honors & Awards
| 2013 - 2021 | Houstonia Top Doctors |
| 2006 | APGO Excellence in Teaching Award |
| 2005 - 2006 | Medical Student Educator of the Year, Baylor College of Medicine |
| 2004 - 2017 | Texas Super-Doc |
| 2004 | Americas Top Obstetricians and Gynecologists |
| 2004 | Educator of the Month, October, The University of Texas MD Anderson Cancer Center |
| 2003 - 2014 | Best Doctors in America |
| 2003 | Gynecologic Exceptional Teaching Award, Baylor College of Medicine |
| 2003 | Outstanding Educator, The University of Texas MD Anderson Cancer Center |
| 1994 | Outstanding Resident Teaching Award, The University of Texas Southwestern Medical School, Parkland Memorial Hospital |
| 1994 | Texas Residents Research Symposium Award for Best Resident Research Project, The University of Texas Southwestern Medical School, Parkland Memorial Hospital |
Professional Memberships
Selected Presentations & Talks
Formal Peers
- 2021. Endometrial and Ovarian Cancer Updates. Invited. Houston, TX, US.
- 2008. HPV Vaccine. Invited. Lubbock, TX, US.
- 2008. Surgical Anatomy. Invited. Houston, TX, US.
- 2008. Management of GTD. Invited. Houston, TX, US.
- 2007. Management of Endometrial Cancer. Invited. Houston, TX, US.
- 2007. Management of Endometrial Cancer. Invited. Houston, TX, US.
- 2007. Surgical Anatomy. Invited. Houston, TX, US.
- 2004. Management of Cervix Cancer. Invited. Houston, TX, US.
- 2003. Current HRT News. Invited. Dallas, TX, US.
- 2002. HRT and Cancer Risks. Invited. Lubbock, TX, US.
- 2001. Overview on Gynecological Cancer. Invited. Lufkin, TX, US.
- 1999. New Developments in Treatments for Ovarian Cancer. Invited. College Station, TX, US.
- 1998. Early Ovarian and Endometrial Cancer. Invited. San Antonio, TX, US.
- 1998. Update on Ovarian Cancer. Invited. Beaumont, TX, US.
Grant & Contract Support
| Date: | 2023 - 2028 |
| Title: | MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 2U01CA200462 |
| Date: | 2004 - 2009 |
| Title: | Social Cognitive Theory and PA after Endometrial Cancer |
| Funding Source: | National Cancer Institute |
| Role: | Co-I |
| ID: | 1 R01 CA109919-01 |
| Date: | 2000 - 2002 |
| Title: | Identifying Factors Associated With Early Detection of Ovarian Cancer |
| Funding Source: | Centers for Disease Control and Prevention |
| Role: | Collaborator |
| ID: | U48/CCU609653-08 SIP 15-00 |
Selected Publications
Peer-Reviewed Articles
- Repollet Otero, PA, Ramalingam, P, Bevers, MW, Malpica, A. High-grade Invasive Papillary Urothelial Carcinoma Arising in a Mature Cystic Teratoma of the Ovary. International Journal of Gynecological Pathology Publish Ahead of Print, 2026. e-Pub 2026. PMID: 42318900.
- Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta D, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC Jr. Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol 42(10):1102-1109, 2024. e-Pub 2024. PMID: 38194613.
- Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AK. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer 31(1):92-97, 2021. e-Pub 2021. PMID: 33154095.
- Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol 204(4):355.e1-7, 2011. e-Pub 2011. PMID: 21324431.
- Ramirez PT, Frumovitz M, Dos Reis R, Milam MR, Bevers MW, Levenback CF, Coleman RL. Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy. Int J Gynecol Cancer 18(3):571-5, 2008. e-Pub 2008. PMID: 17692091.
- Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JA. Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. J Oncol Pharm Pract 14(1):31-6, 2008. e-Pub 2008. PMID: 18337438.
- Said HK, Bevers M, Butler CE. Reconstruction of the pelvic floor and perineum with human acellular dermal matrix and thigh flaps following pelvic exenteration. Gynecol Oncol 107(3)(3):578-82, 2007. e-Pub 2007. PMID: 17919700.
- Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW, Brown J, Slomovitz BM, Ramirez PT. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol 110(1):96-102, 2007. e-Pub 2007. PMID: 17601902.
- Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback C. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol 102(3):534-6, 2006. e-Pub 2006. PMID: 16483643.
- de Moor JS, de Moor CA, Basen-Engquist K, Kudelka A, Bevers MW, Cohen L. Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy. Psychosom Med 68(4):555-62, 2006. e-Pub 2006. PMID: 16868264.
- Stevens TA, Brown J, Zander DS, Bevers MW, Gershenson DM, Ramondetta LM. Adult granulosa cell tumors of the ovary in two first-degree relatives. Gynecol Oncol 98(3):502-5, 2005. e-Pub 2005. PMID: 15992917.
- Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EB. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13(4):219-27, 2005. e-Pub 2005. PMID: 15538640.
- Ramirez PT, Sun CC, Vidal CI, Schimp V, Slomovitz BM, Bevers MW, Bodurka DC. Outcomes of hysteroscopy and hysterectomy in breast cancer patients. Cancer Ther 3:147-152, 2005. e-Pub 2005.
- Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Frozen section analyses as predictors of lymphatic spread in patients with early stage uterine cancer. J Am Coll Surg 199(3):388-393, 2004. e-Pub 2004. PMID: 15325608.
- Donato ML, Aleman A, Champlin RE, Saliba RM, Wharton JT, Burke TW, Bodurka DC, Bevers MW, Levenback CF, Wolf JK, Bast RC, Freedman RS, Ippoliti C, Brewer M, Gajewski JL, Gershenson DM. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 33(12):1219-24, 2004. e-Pub 2004. PMID: 15122311.
- Ramondetta LM, Burke TW, Jhingran A, Schmandt R, Bevers MW, Wolf JK, Levenback CF, Broaddus R. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets. Gynecol Oncol 90(3):529-36, 2003. e-Pub 2003. PMID: 13678720.
- Ramirez PT, Modesitt SC, Morris M, Edwards CL, Bevers MW, Wharton JT, Wolf JK. Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies. Gynecol Oncol 85(2):285-91, 2002. e-Pub 2002. PMID: 11972389.
- Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC Jr, Gajewski JL, Champlin RE. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol 82(3):420-6, 2001. e-Pub 2001. PMID: 11520135.
- Hortobagyi GN, Ueno NT, Xia W, Zhang S, Wolf JK, Putnam JB, Weiden PL, Willey JS, Carey M, Branham DL, Payne JY, Tucker SD, Bartholomeusz C, Kilbourn RG, De Jager RL, Sneige N, Katz RL, Anklesaria P, Ibrahim NK, Murray JL, Theriault RL, Valero V, Gershenson DM, Bevers MW, Huang L, Lopez-Berestein G, Hung MC. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol 19(14):3422-33, 2001. e-Pub 2001. PMID: 11454891.
- Ramondetta L, Burke TW, Levenback C, Bevers MW, Bodurka-Bevers D, Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol 82(1):156-161, 2001. e-Pub 2001.
- Levenback C, Coleman R, Burke TW, Bevers M, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83(2):276-281, 2001. e-Pub 2001.
- Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78(2):187-93, 2000. e-Pub 2000. PMID: 10926801.
- Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J, Gershenson DM. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 77(1):183-9, 2000. e-Pub 2000. PMID: 10739709.
- Donato ML, Gershenson D, Ippoliti C, Wharton JT, Bast RC, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin RE. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant 25(11):1137-1140, 2000. e-Pub 2000.
- Moon C, Verschraegen CF, Bevers M, Freedman R, Kudelka AP, Kavanagh JJ. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity. Anti-Cancer Drugs 11(7):565-568, 2000. e-Pub 2000.
- Verschraegen CF, Levenback C, Vincent M, Wolf J, Bevers M, Loyer E, Kudelka AP, Kavanagh JJ. Phase II study of intravenous Dx-891f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Ann N Y Acad Sci 922:349-351, 2000. e-Pub 2000.
- Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer 85(4):905-11, 1999. e-Pub 1999. PMID: 10091769.
Professional Educational Materials
- Bevers MW. Endoscopy, Gastrostomy, and Related Procedures. 6, 2001.
- . The University of Texas MD Anderson Gynecologic Oncology Handbook, 1996.
Abstracts
- Frumovitz M, Slomovitz BM, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Endometrial cancer: To stage or not to stage, part II. Gynecol Oncol 92(1):487, 2004. e-Pub 2004.
- Bodurka DC, Sun CC, Weaver CB, Jennings J, Melancon CH, Bevers MW, Wolf JK, Ramirez PT, Gershenson DM, Lairson DR. Ovarian cancer (OV CA): The cost of caregiving. Gynecol Oncol 92(1):456, 2004. e-Pub 2004.
- Bodurka DC, Frumovitz M, Sun CC, Ramirez PT, Bevers MW, Gershenson DM. Laparoscopy for probable ovarian cancer: less may not be more. Gynecol Oncol 88(2):244, 2003. e-Pub 2003.
- Ramirez PT, Vidal CI, Schimp VL, Sun CC, Slomovitz BM, Bevers MW, Bodurka DC. Indications and outcomes of hysteroscopy and hysterectomy in breast cancer patients. Gynecol Oncol 88(2):216, 2003. e-Pub 2003.
- Ramondetta LM, Broaddus R, Wolf JK, Levenback C, Bevers M, Burke TW. A phase II trial of cisplatin and ifosfamide/mesna in patients with advanced or recurrent uterine mixed Mullerian tumors. Proceedings of the American Society of Clinical Oncology 21:213a, 2002. e-Pub 2002.
- Donato ML, Aleman AS, Gershenson DM, Wharton JT, JrRC B, Burke TW, Bodurka Bevers D, Bevers MW, Levenback CF, Wolf JK, Freedman RS, Cooke S, Ippoliti C, Brewer M, Gajewski JL, Champlin RE. Long term results of 102 patients with advanced ovarian cancer treated with high-dose chemotherapy. Proceedings of the American Society of Clinical Oncology 20:204a, 2001. e-Pub 2001.
- Levenback C, Coleman RL, Burke TW, Bevers MW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping of the vulva with blue dye. Gynecol Oncol 76(2):234, 2000. e-Pub 2000.
- Donato ML, Gershenson D, Ippoliti C, Wharton JT, Jr BR, Aleman A, Anderlini P, Gajewski JG, Giralt S, Molldrem J, Ueno N, Lauppe J, Korbling M, Boyer J, Bodurka-Bevers D, Bevers M, Burke T, Freedman R, Levenback C, Wolf J, Champlin RE. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant 25:1137-1140, 2000. e-Pub 2000.
- Bodurka-Bevers D, Lu K, Wolf JK, Bevers MW, Branham D, Silva EG, Gershenson DM. The clinical course of low-grade serous carcinoma of the ovary. Gynecol Oncol 76(2):255, 2000. e-Pub 2000.
- Parker LP, Parker JR, Deavers M, Bodurka-Bevers D, Bevers MW, Price JR, Gershenson DM. Prognostic factors and role of immunohistochemistry in Paget’s disease of the vulva. Cancer J Sci Med 6:112, 2000. e-Pub 2000.
- Verschraegen CF, Levenback C, Vincent M, Wolf J, Bevers M, Loyer E, Kudelka AP, Kavanagh JJ. Phase II study of intravenous Dx-891f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Proceedings of the American Society of Clinical Oncology 16a:1550, 2000. e-Pub 2000.
- Donato ML, Gershenson DM, Ippoliti C, Wharton JT, Bevers MW, Bodurka-Bevers DC, Levenback CF, Wolf JK, Freedman RS, Jr BR, Burke TW, Champlin RE. Topotecan in combination with cyclophosphamide and melphalan for stem cell transplantation: Results of a large phase I trial in advanced ovarian cancer. Proceedings of the American Society of Clinical Oncology 19:50a, 2000. e-Pub 2000.
- Bodurka-Bevers D, Basen-Engquist KM, Fitzgerald MA, Bevers MW, Wolf JK, Levenback C, Gershenson DM. Depression may worsen quality of life in patients with epithelial ovarian cancer. . Gynecol Oncol 72:449, 1999. e-Pub 1999.
- Parker LP, Parker JR, Bevers DB, Deavers M, Price JR, Atkinson EN, Bevers MW, Gershenson DM. Risk factors for recurrence and poor prognostic factors of patients with Paget's disease of the vulva. Gynecol Oncol 72:463, 1999. e-Pub 1999.
- Donato M, Gershenson D, Wharton JT, Aleman A, Ippoliti C, Bodurka D, Levenback C, Bevers M, Wolf J, Freedman R, Gajweski J, Bast R, Champlin RE. Phase I study of high-dose topotecan and alkylating agents for advanced ovariancancer. Proceedings of the American Society of Clinical Oncology 18:44a, 1999. e-Pub 1999.
- Dalrymple JL, Levenback C, Wolf JK, Bevers DB, Bevers MW, Gershenson DM. End of life care for inpatient gynecologic oncology patients. Proceedings of the American Society of Clinical Oncology 18:578a, 1999. e-Pub 1999.
- Verschraegen C, Kudelka AP, Bevers M, Edwards CL, Freedman RS, Steger M, Wharton JT, Kavanagh JJ. Endocrine response following subcutaneous injections of Cetro-relix in postmenopausal women. Proc of the AACR Meeting 39:3270, 1998. e-Pub 1998.
- Lin PS, Gershenson DM, Bevers MW, Lucas KR, Silva EG. Current surgical staging of serous borderline ovarian tumors. ACOG Abstract Book:80, 1998. e-Pub 1998.
- Basen-Engquist K, Pentz R, DeJesus Y, Greisinger A, Anderlick M, Smith T, Gershenson D, Wolf JK, Bodurka D, Bevers M, Levenback C. Advance Care Planning for the End of Life. J Cancer Education 13(3):31, 1998. e-Pub 1998.
- Kudelka AP, Kavanagh JJ, Freedman RS, Wolf JK, Gershenson DM, Bevers MW, Huang L, Lopez-Berenstein G, Hortobagyi GN. Phase I E1A gene therapy in patients with advanced breast and ovarian cancer. Proc of the AACR Meeting 39:2458, 1998. e-Pub 1998.
- Brewer MA, Bodurka DC, Bevers M, Gershenson DM, Burke TM, Wolf JK. Postoperative nasogastric intubation in gynecologic oncology patients. Gynecol Oncol 68:126, 1998. e-Pub 1998.
- Ueno NT, Hung MC, Zhang S, Xia W, Willey JS, Warner DL, Payne JY, Nandagiri R, Aldridge R, De Jager RL, Tucker S, Putnam JB, Sneige N, Katz RL, Spohn WH, Bast RC, Holmes FA, Ibrahim NK, Theriault RL, Rahman ZU, Valero V, Kudelka AP, Kavanagh JJ, Freedman RS, Wolf JK, Gershenson DM, Bevers MW, Huang L, Lopez-Berestein G, Hortobagyi GN. Phase I E1A gene therapy in patients with advanced breast and ovarian cancer. Proceedings of AACR Meeting 39:2458, 1998. e-Pub 1998.
- Donato M, Gershenson D, Wharton JT, Ippoliti C, Bodurka D, Levenback C, Gajweski J, Bevers M, Freedman R, Edwards C, Wolf J Champlin RE. Phase I study of high-dose alkylating agents and topotecan for advanced ovarian cancer. Proceedings of the American Society of Clinical Oncology 17:75a, 1998. e-Pub 1998.
- Vadan-Raj S, Verschraegan C, McGarry L, Bueso-Ramos C, Kudelka A, Freedman R, Edwards C, Bevers M, Levenback C, Gershenson D, Jones D, Yang T, Bast RC, Kavanagh JT. Recombinant human thrombocytopenia (rhTPO) attenuates high-dose carboplatin (C)-induced thrombocytopenia in patients with gynecologic oncology. American Society of Hematology 39th Annual Meeting 90, 1997. e-Pub 1997.
- Bodurka DC, Levenback C, Bevers MW, Munkarah AR, Burke TW, Price K, Gershenson DM. Outcomes of gynecologic oncology patients with adult respiratory distress syndrome. Gynecol Oncol 64:160, 1997. e-Pub 1997.
Book Chapters
- Bevers MW, Bodurka-Bevers DC, Wolf JK. Gynecologic Cancers. In: The M. D. Anderson Surgical Oncology Handbook; Third Edition. Lippincott Williams & Wilkins, 445-490, 2003.
- Bodurka-Bevers D, Follen M, Bevers MW. Preinvasive disease of the lower female genital tract. In: Handbook of Gynecologic Oncology. Chapter 10. Martin Dunitz Ltd, 197-205, 2000.
- Bodurka-Bevers D, Bevers MW, Sukumaran A. Critical Care. In: Handbook of Gynecologic Oncology. Chapter 5. Martin Dunitz Ltd, 87-109, 2000.
- Bevers MW, Bodurka-Bevers DC, Wolf JK. Gynecologic Cancers. In: The M. D. Anderson Surgical Oncology Handbook; Second Edition. Lippincott Williams & Wilkins, 377-424, 1998.
Books (edited and written)
- Barakat RR, Bevers MW, Gershenson DM, (eds) HW. Handbook of Gynecologic Oncology. Martin Dunitz Ltd, 2002.
- Barakat RR, Bevers MW, Gershenson DM, (eds) HW. Handbook of Gynecologic Oncology. Martin Dunitz Ltd, 2000.
Patient Reviews
CV information above last modified September 04, 2026